Place two packs of CBD seeds next to each other, one labelled 1:1 and the other 20:1, and they look the same: same breeder’s packaging, same seed count, seeds that no eye can tell apart. Run them in the same tent and they part ways at the very first stage and never converge again. The cause is a single gene, and the easiest way to understand what it does is to follow the two packs through each step they go through: the breeding that produced them, the seed, the seedling, the flower tent, the harvest, the jar, the lab report and the border. The ratios quoted as reference points below are drawn from the range at https://calmcbdseeds.com, which goes 1:1, 2:1 and 20:1 with a top line at about 30 to one; the biology is the same regardless of which shop the seeds come from.
Before the Seed Exists
Cannabis settles if it will produce THC or CBD at one locus on the genome. The gene there exists in two versions: one codes the enzyme that converts the shared precursor into THCA, the other the enzyme that converts it into CBDA. Each plant holds two copies, one received from each parent, and the combination fixes the chemotype. Two THC copies make a THC-dominant plant. Two CBD copies make a CBD-dominant one. One of each gives a balanced plant, because the two versions are codominant and neither overrides the other.
The balanced pack was made by crossing two balanced plants, each carrying one copy of each version. The 20:1 pack was bred by crossing two plants that each carry two CBD copies and no THC copy in either of them. That one fact at the cross decides everything downstream, and it is already inside the seed long before it is packed.
Stage Two: Inside the Seed
Cross two balanced plants and the offspring sort themselves by the oldest arithmetic in genetics: a quarter get two THC copies, a quarter get two CBD copies, half inherit one of each. In a pack of 10 seeds that means, on average, around two THC-dominant seeds, two or three CBD-dominant ones, and five true balanced seeds. The pack is sold by its parents, and for half its seeds the label fits; for the other half it does not. Calm CBD Seeds states the expected split on each balanced line, which means the buyer sees before planting that a portion of the plants will differ from the headline ratio.
The 20:1 pack has no such split. Each seed got a CBD copy from both parent, each plant will be CBD-dominant, and the ratio on the foil holds to every one of them, within the ordinary differences in how much total cannabinoid an individual plant produces. The trade describe such lines “breed true” for chemotype; the term means exactly this absence of surprise.
Where Nothing Shows
Here the two packs look alike once more, and the resemblance holds further than many growers assume. Chemotype leaves no mark on a seedling. Leaf shape, colour, internode spacing and the speed of growth are controlled by different genes altogether, and the three chemotypes of plant in the balanced pack come up without any visible difference from one another and from each plant in the 20:1 pack.
The one real distinction during this stage arises from lineage not chemotype. Strains with strong hemp ancestry, which covers some older CBD-dominant lines, are inclined to stretch taller and branch less. A heavily selected 20:1 line behaves like any modern hybrid; a early-generation one still shows the hemp in its shape. Not one of these tendency tells anything about the ratio in the flower.
Frost, Smell and the Wrong Conclusions
In flower the two packs start to offer clues, and the majority of the clues point the wrong way. Resin coverage is the first thing a grower judges, and it was a reasonable guide: first-generation CBD-dominant strains showed visibly less resin than their THC cousins, an unwanted inheritance from hemp. Current lines have mostly erased that gap, and a less resinous plant from the 20:1 pack can still test precisely where the foil promised. Resin density and chemotype are carried separately.
Smell is an even poorer guide. The terpene chemistry sits on yet different genes, so the THC-dominant plant sitting in the balanced pack can be identical to the balanced one beside it, and both can smell indistinguishable to a plant from the 20:1 pack. Growers who try to separate a balanced pack by nose at week eight are guessing, which is no any better than not sorting at all.
Stage Five: The Harvest Window
At this stage the two packs diverge in a way that favours the grower of the 20:1 pack and also the CBD-dominant plants sitting in the balanced pack. CBDA breaks down more slowly than THCA, so a CBD-dominant plant left a week beyond its peak retains the bulk of its cannabinoid content, whereas a THC-dominant one under the same neglect has by then begun converting THC to CBN. The cloudy rules nonetheless holds; it holds because the terpenes, which fade on every plant regardless the chemotype, and a late, over-dried CBD flower smells of little whatever the lab result says.
Stage Six: The Jar
The 20:1 pack goes into one jar. Each plant from it holds roughly the same ratio, and mixing them alters nothing worth measuring. The balanced pack cannot be handled that way. Blend its 10 plants in a single jar and the result become a mixture that no foil ever predicted, skewed by whichever plants grew biggest, and nothing on a subsequent test can pull apart the plants that went in.
The discipline that saves the grief is almost tedious: cut the balanced pack plant by plant, dry every one apart, label each, and try them plant at a time before anything is mixed. It is the only point in the whole process at which the different kinds of plant in the balanced pack can still be kept apart without a lab, and only because every one is still in its own bag.
Reading the Two Results
Send a sample from each jar to a laboratory and the two packs finally are legible. For the 20:1 pack the reports arrive back grouped closely near the advertised ratio, varying mostly in total cannabinoid content rather than in balance. For the balanced pack they arrive back in three clusters: some plants showing almost all THC, some showing nearly all CBD, and the rest sitting near one to one. No part of this pattern is a failure; it is the breeder’s cross written out as numbers.
Over-the-counter test kits exist for growers without a laboratory, and most detect whether THC is present but not how much. That is sufficient to pull the THC-dominant plants away of a balanced pack and insufficient to assign a ratio to the rest, and that matches the most frequent use: finding out which of the 10 jars is going to surprise a guest.
Where the Law Reads the Numbers
The last stage where the two packs diverge is legal, and it catches growers who thought “CBD” meant “hemp”. The majority of jurisdictions classify hemp by a THC limit, a small fraction of a percent of dry weight, and the precise number differing from country and sometimes year to year. A plant from the 20:1 pack producing twenty percent CBD at twenty to one also produces around one percent THC, which is many times over most thresholds. Certified hemp cultivars are bred to keep total cannabinoid output low so the THC share remains below the line right up to harvest; CBD seed lines are selected for high output and let the THC scale with it. A shop that gives only a ratio is selling a flower line; anyone who needs a compliant crop needs to ask for a tested THC figure at maturity and buy no line that cannot provide one.
Beyond the threshold issue, the chemotype changes nothing in the law on the seed as such. Where owning cannabis seeds is permitted and germinating them is not, the balanced pack and the 20:1 pack sit under the same position as every other pack. Where the plant is permitted outright, the choice between them is a matter of preference and nobody else’s. None of this article is legal advice, and the law which applies is the one in the place the seed is going to be sown, rather than the one in the place it was bought.

